Related Experiment Video
Updated: Jul 21, 2025

10:41
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
14.1K
Immune thrombocytopenia associated with lymph node tuberculosis: a case report.
Juliano Córdova Vargas1,2,3,4, Patrícia Nunes Bezerra4, Murilo Sequeira4
1Américas Oncologia e Hematologia, Departamento de Hematologia, São Paulo, SP, Brasil.
Revista Da Sociedade Brasileira De Medicina Tropical
|July 26, 2023
Summary
Extrapulmonary tuberculosis is rarely linked to immune thrombocytopenia (ITP). This case highlights a potential association, as tuberculosis treatment normalized critically low platelet counts in a patient with pulmonary and lymph node TB.
Area of Science:
- Internal Medicine
- Infectious Diseases
- Hematology
Background:
- Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low platelet counts.
- Tuberculosis (TB), a serious infectious disease, can manifest in various forms, including extrapulmonary disease.
- The co-occurrence of ITP and tuberculosis is exceptionally rare, particularly when TB affects both pulmonary and lymph node sites.
Observation:
- A 29-year-old male presented with severe thrombocytopenia (platelet count of 4,000/µL).
- Diagnostic imaging revealed mediastinal adenomegaly, aortic lymph node clusters, and left upper lung lobe consolidation.
- Histopathological examination of lung tissue confirmed active tuberculosis.
Findings:
- The patient received intravenous immunoglobulin and methylprednisolone, followed by a standard four-drug anti-tuberculosis regimen (rifampicin, isoniazid, pyrazinamide, ethambutol).
- Corticosteroid therapy was gradually withdrawn.
- Platelet counts normalized following successful treatment of tuberculosis.
Implications:
- This case suggests a potential causal association between tuberculosis infection and the development of immune thrombocytopenia.
- Early diagnosis and treatment of tuberculosis may lead to the resolution of associated ITP.
- Further research is warranted to elucidate the immunological mechanisms underlying this rare association.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis III
365
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
365
Pulmonary Tuberculosis IV
165
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
165
Pulmonary Tuberculosis I
269
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
269
Pulmonary Tuberculosis II
265
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
265
Pulmonary Tuberculosis V
201
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
201

